Use of Advisory Committees by the Food and Drug Administration: Hearings Before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, Second Session ...

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee

U.S. Government Printing Office, 1975 - Citizens' advisory committees in science - 556 pages

Contents

• Hearings held on Page: 1
• Code of Federal Regulations excerpts pp 231 through 236 of part 141 to Page: 5
• Ayerst Laboratories Epitrate drug recall letter February 26 1971 76: 26
• ܒܗ: 30
• August 8 1972 from Gerald F Meyer Office of Legislative Services FDA: 85
• May 16 1975 letter from Chairman Fountain to FDA Commissioner: 115
• May 17 1975 letter from Peter B Hutt Chief Counsel FDA to L: 175
• Amended FDA Advisory Committee cost estimates for years 1972 and 1973 Page: 253
• Excerpt from the Federal Register of June 5 1975 entitled Aerosol: 262
• Not Misbranded 510: 265
• June 20 1972 letter to Procter Gamble from Paul A Bryan: 331
• December 8 and 9 1972 meetings 122123: 363
• MEMORANDUMS: 372

Bibliographic information

• Title: Use of Advisory Committees by the Food and Drug Administration: Hearings Before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, Second Session ...; Part 2 of Use of Advisory Committees by the Food and Drug Administration: Hearings Before a Subcommittee of the Committee on Government Operations, House of Representatives, Ninety-third Congress, Second Session, United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee
• Author: United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee
• Publisher: U.S. Government Printing Office, 1975
• Original from: Purdue University
• Digitized: Jun 7, 2012
• Length: 556 pages